S9-CMC1 TFA
S9-CMC1 TFA is a covalent peptide lysine-specific demethylase 1 (LSD1) inhibitor with an IC50 value of 2.53 μM. S9-CMC1 TFA specifically recognizes Cys360 in the enzyme-active region. S9-CMC1 TFA inhibits LSD1 activity, increasing H3K4me1 and H3K4me2 levels, leading to G1 cell cycle arrest and apoptosis and inhibiting cell proliferation. S9-CMC1 TFA significantly inhibits tumor growth in A549 xenograft animal models.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C97H151F3N32O17S2
- Masse moléculaire:2158.57
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
Chemical Information
-
Masse moléculaire 2158.57
-
Formule C97H151F3N32O17S2
-
Sequence
Ac-Pro-Arg-cyclo(Cys-Phe-Leu-Val-Met)-Lys-Pro-Arg-Arg-Arg-Arg-Trp-NH2 (Cyclization Bridge via Benzene-1,3-bismethylene: Cys3-Met7)
-
Sequence Shortening
Ac-PR-Cyclo(CFLVM)-KPRRRRW-NH2 (Cyclization Bridge via Benzene-1,3-bismethylene: Cys3-Met7)
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
S9-CMC1 TFA Related Classifications
HY-P10819 Related Classifications
Powered by Bioz